Concepedia
Statistics
Publications
49
Citations
2.9K
H-Index
21
Active since
2011
Affiliations
University of California, San Francisco(Current)
Oregon Health & Science University
University Hospital of Geneva
University of Georgia
Oklahoma State University Center for Health Sciences
Alyson Haslam is an author at University of California, San Francisco specializing in oncology, medicine, and pharmacology.
Publications per year
2011–2025
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam, Vinay Prasad · JAMA Network Open · 2019 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +15
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs
Alyson Haslam, Jennifer Gill, Vinay Prasad · JAMA Network Open · 2020 · 275 citations · Full text
Medicine, Oncology, Pharmacology +13
FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019
Emerson Y. Chen, Alyson Haslam, Vinay Prasad · JAMA Internal Medicine · 2020 · 121 citations · Full text
Pharmacy, Clinical Pharmacokinetics, Oncology +16
Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of Action
Timothée Olivier, Alyson Haslam, Vinay Prasad · JAMA Network Open · 2021 · 116 citations · Full text
Medicine, Oncology, Pharmacology +8
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
Alyson Haslam, Minki Kim, Vinay Prasad · Annals of Oncology · 2021 · 100 citations · Full text
Medicine, Oncology, Pharmacotherapy +8
1–5 of 49